Objective, quantitative scores mapped to established diagnostic categories, replacing reliance on symptom checklists alone.
From objective diagnosis to precision treatment.
Psychoverse is the psychiatric instance of Cytoverse, Cytognosis’s general map of human biology. It is our first deployment of that platform, built where the human cost is highest, not the only place the platform will ever go.
Three deliverables
One map, three things it makes possible.
The Psychoverse Precision Psychiatry Platform delivers three connected outcomes, each building on the one before it.
Not a diagnosis. The goal is never to diagnose from a website or reduce a person to a score, only to make biological patterns easier to measure, discuss, and act on with a clinician.
A person’s specific biological phenotype and likely mechanism, not a population average applied to an individual.
Treatment and lifestyle options prioritized by biotype match, so the first thing tried is more likely to be the right thing.
One platform, first deployment
Psychoverse is where we start, not where the platform stops.
Cytoverse is disease-agnostic by design. Psychoverse is its psychiatric instance, and the same map, sensors, and on-device guidance are built to extend to other indication lines over time.
Neuropsychiatric disease is our flagship, not because the platform is limited to it, but because four things converge there with unusual clarity: the underlying biology is demonstrated in continuous, transdiagnostic terms rather than fixed categories; noninvasive sensing of brain and mental states is mature enough to use today; noninvasive interventions already work and improve further when personalized; and our team has built foundational atlases in exactly this area.
The architecture underneath Psychoverse, Cytoverse for the map, Cytoscan for continuous sensing, Cytostat for the live coordinate, and Cytopolis for on-device guidance, is the same architecture that later extends to immune, metabolic, and oncologic disease under different name prefixes. Proving it in the brain is the proving ground for the rest.
How each deliverable gets there
Three validation stages per deliverable.
This section is early and directional; the fuller staging model is still being written, so treat the order below as a working plan, not a locked roadmap or a timeline commitment.
Single-disease
Validate within one diagnostic category before asking the model to generalize.
Transdiagnostic
Test whether the same biological axes hold across categories the ICD treats as unrelated.
Clinically-ready
Reach the evidence and workflow bar a clinician could actually use.
Public dashboard preview
From biological signal to a treatment recommendation.
This is an illustrative public view, not live personal data. It shows how Psychoverse connects diagnosis, biotyping, and treatment guidance to Yar as a product surface.
Example clusters
Signal areas we are mapping
MoodHigh
AttentionHigh
SleepMed
AutonomicMed
Product bridge
Yar surfaces
Voice capture, mood-aware pacing, and companion tone are the first product expressions of the Psychoverse direction; deeper biotyping and treatment guidance stay clinician-connected, not self-served.
Meet YarResearch direction
Open questions
Which biological axes hold up across diagnostic categories? Which noninvasive signals are strong enough to act on? Which supports feel humane rather than surveilled?
Read our research directionLightweight feedback
Tell us what kind of support language feels useful.
This is not a symptom screener. It is a way to share which parts of the objective-diagnosis, biotyping, or treatment direction feel worth exploring, or which wording feels off.